The global veterinary POC diagnostic market was valued at $1.41 billion in 2020 and is projected to reach $2.62 billion by 2028, growing at a CAGR of 7.99% from 2021 to 2028. This growth is driven by several macro and microeconomic factors, including the increasing frequency of zoonotic diseases in animals, which is a key driving factor for veterinary POC diagnostics.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Product (Consumables, Instruments)
By Technology (Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Others)
By Animal Type (Companion Animals, Livestock Animals)
By End Use (Veterinary Clinics, Veterinary Hospitals and Academic Institutes, Home Care Settings)
Key players
Zoetis
IDEXX Laboratories, Inc.
Heska Corporation
Virbac
Thermo Fisher Scientific, Inc.
Eurolyser Diagnostica GmbH
Woodley Equipment Company
Randox Laboratories LTD.
AniPOC, Ltd.
FUJIFILM SonoSite
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook